Features of BAFF and APRIL receptors on circulating B cells in antineutrophil cytoplasmic antibody-associated vasculitis

被引:4
|
作者
Shimojima, Yasuhiro [1 ]
Kishida, Dai [1 ]
Ichikawa, Takanori [1 ]
Takamatsu, Ryota [1 ]
Nomura, Shun [1 ]
Sekijima, Yoshiki [1 ]
机构
[1] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Japan
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2023年 / 213卷 / 01期
基金
日本学术振兴会;
关键词
ANCA-associated vasculitis; BAFF; APRIL; BAFF-R; TACI; B-cell subsets; PRIMARY SJOGRENS-SYNDROME; ACTIVATING FACTOR; SERUM-LEVELS; BLYS; BIOLOGY; LYMPHOCYTE; DEFICIENCY; TREG; TACI;
D O I
10.1093/cei/uxad024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the features of circulating B cells, their expressing receptors, serum levels of B-cell activation factor of the TNF family (BAFF), and a proliferation-inducing ligand (APRIL) in antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Blood samples from 24 patients with active AAV (a-AAV), 13 with inactive AAV (i-AAV), and 19 healthy controls (HC) were included in this study. The proportion of B cells and their expressing BAFF receptor (BAFF-R), transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), and B-cell maturation antigen were analyzed via flow cytometry. Serum levels of BAFF, APRIL, and interleukin (IL)-4, IL-6, IL-10, and IL-13 were also evaluated using an enzyme-linked immunosorbent assay. The proportion of plasmablasts (PB)/plasma cells (PC) and serum levels of BAFF, APRIL, IL-4, and IL-6 were significantly higher in a-AAV than in HC. Higher serum levels of BAFF, APRIL, and IL-4 were observed in i-AAV than in HC. Lower expression of BAFF-R on memory B cells and higher expression of TACI on CD19+ cells, immature B cells, and PB/PC were demonstrated in a-AAV and i-AAV than in HC. The population of memory B cells was positively associated with serum APRIL levels and BAFF-R expression in a-AAV. In conclusion, decreased expression of BAFF-R on memory B cells and increased expression of TACI on CD19+ cells, immature B cells, and PB/PC, as well as increased serum levels of BAFF and APRIL, were sustained even in the remission phase of AAV. Persistent aberrant signaling of BAFF/APRIL may contribute to disease relapse. Significantly decreased BAFF-R or increased TACI expression on B-cell subsets were observed in ANCA-associated vasculitis (AAV). Increased serum levels of BAFF and APRIL remained even in AAV remission. APRIL and BAFF-R were positively associated with memory B cell expression in active AAV.
引用
收藏
页码:125 / 137
页数:13
相关论文
共 50 条
  • [21] Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody-associated vasculitis
    Sullivan, Megan M.
    Abril, Andy
    Aslam, Nabeel
    Ball, Colleen T.
    Berianu, Florentina
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [22] Outcome measures for antineutrophil cytoplasmic antibody-associated vasculitis
    Tomasson, Gunnar
    CURRENT OPINION IN RHEUMATOLOGY, 2015, 27 (01) : 38 - 44
  • [23] Maintenance Immunosuppression in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Cattran, Daniel C.
    Hladunewich, Michelle A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (06) : 818 - 821
  • [24] The Expanding Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Armamentarium
    Mcgovern, Dominic P.
    Jones, Rachel B.
    Jayne, David R. W.
    Smith, Rona M.
    DRUGS, 2025, 85 (03) : 325 - 341
  • [25] Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis
    McGregor, JulieAnne G.
    Hogan, Susan L.
    Kotzen, Elizabeth S.
    Poulton, Caroline J.
    Hu, Yichun
    Negrete-Lopez, Roberto
    Kidd, Jason M.
    Katsanos, Suzanne L.
    Bunch, Donna O.
    Nachman, Patrick H.
    Falk, Ronald J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i123 - i131
  • [26] Current Landscape of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Lally, Lindsay
    Spiera, Robert
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2015, 41 (01) : 1 - +
  • [27] The role of complement in antineutrophil cytoplasmic antibody-associated vasculitis
    Trejo, Maria A. C. Wester
    Trouw, Leendert A.
    Bajema, Ingeborg M.
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (01) : 3 - 8
  • [28] Renal Involvement in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Zonozi, Reza
    Niles, John L.
    Cortazar, Frank B.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2018, 44 (04) : 525 - +
  • [29] Relapse Prediction in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Riogh, Eithne Nic an
    Little, Mark A.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (10) : 1473 - 1474
  • [30] Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Micheletti, Robert G.
    Fuxench, Zelma Chiesa
    Craven, Anthea
    Watts, Richard A.
    Luqmani, Raashid A.
    Merkel, Peter A.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (10) : 1741 - 1747